Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inclisiran in Indian Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
NCT06386419Phase 4Completed
- Sponsor
- Novartis
- Start
- Nov 2024
- Primary completion
- Jan 2026
- Modality
- Antisense DNA, Conjugated siRNA, MicroRNA (miRNA)
- Countries
- 1
01
Overview
A Phase 4 trial of inclisiran in hypercholesterolemia, mixed dyslipidemia, sponsored by Novartis. Started Nov 2024; status: completed.
02
Drugs
inclisiran
03
Conditions
hypercholesterolemiamixed dyslipidemia
Beyond the preview
Go deeper on NCT06386419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06386419.